Immune dysregulation in cancer patients developing immune-related adverse events

BACKGROUND: Up to 40% of cancer patients on immune checkpoint inhibitors develop clinically significant immune-related adverse events (irAEs). The role of host immune status and function in predisposing patients to the development of irAEs remains unknown. METHODS: Sera from 65 patients receiving im...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Br J Cancer
Main Authors: Khan, Shaheen, Khan, Saad A., Luo, Xin, Fattah, Farjana J., Saltarski, Jessica, Gloria-McCutchen, Yvonne, Lu, Rong, Xie, Yang, Li, Quan, Wakeland, Edward, Gerber, David E.
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group UK 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6325132/
https://ncbi.nlm.nih.gov/pubmed/30377338
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41416-018-0155-1
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados